RAINIER Phase 2 Study of Solrikitug in Adults with Asthma
Ages: 18-75
Study Reference: NCT06496607
Study Type: Interventional
Learn More at ClinicalTrials.gov
The RAINIER clinical research study is testing an investigational drug, solrikitug, to see how safe it is and how well adults with asthma tolerate it. Researchers will also study how the body processes the drug, whether it causes an immune response, and how it impacts asthma symptoms. Adults aged 18 to 75 who have had asthma for at least a year may qualify. The study is taking place at multiple locations across the United States.
A 52-week study to assess the safety and efficacy of Dexpramipexole, an oral eosinophil lowering therapy, in adolescents and adults with Severe Eosinophilic Asthma (GINA steps 4 and 5).
Ages: 12 and older
Study Reference: NCT05763121
Study Type: Interventional
Learn More at ClinicalTrials.gov
Study Contact: clinicaltrials@areteiatx.com
A 52-week study to assess the safety and efficacy of Dexpramipexole, an oral eosinophil lowering therapy, in adolescents and adults with Severe Eosinophilic Asthma (GINA steps 4 and 5).
Ages: 12 and older
Study Reference: NCT05813288
Study Type: Interventional
Learn More at ClinicalTrials.gov
Study Contact: clinicaltrials@areteiatx.com
